市場調查報告書
商品編碼
1291356
心血管設備市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Cardiovascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球心血管設備市場規模達到554億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到827億美元,在2023-2028年期間呈現6.4%的成長率(CAGR)。
心血管設備是指用於診斷和治療心臟疾病和相關健康問題的各種醫療儀器。它們被設計用來幫助疾病監測和手術干預。一些常用的心血管設備包括支架、心臟瓣膜、移植物、導管、心電圖(ECG)、遠程心臟監測和心臟輔助設備。心血管設備在整個醫療保健領域有廣泛的應用,因為它們有助於有效管理威脅生命的疾病,最大限度地減少病人的不適,並提高生活品質。如今,製造商正專注於開發先進的植入式心血管設備,這使其在全球的需求不斷增加。
由於久坐的生活方式和不健康的飲食模式和習慣,如吸煙和飲酒,促使心血管疾病(CVDs)的廣泛流行,這是推動市場成長的主要因素。除此之外,老年人口的成長是另一個主要的成長誘因,因為他們更容易受到慢性心臟疾病的影響。此外,採用家庭保健設備的情況也有明顯增加。與此同時,對能夠讓病人移動並同時提供即時數據的緊湊型心血管設備的需求不斷增加,這也增強了產品的需求。此外,領先的企業正專注於研究和開發(R&D)活動,推出整合了先進技術和功能的創新產品,從而促進了市場的成長。此外,大眾對現有心血管設備的認知不斷提高,以及對微創(MI)手術的偏好轉變,正在加速產品的採用率。其他因素,包括無線心電圖的推出,對連續和基於家庭的監測需求的成長,以及技術進步,也正在創造一個積極的市場前景。
The global cardiovascular devices market size reached US$ 55.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Cardiovascular devices refer to various medical instruments that are employed for diagnosing and treating heart diseases and related health problems. They are designed to aid in disease monitoring and surgical interventions. Some commonly used cardiovascular devices include stents, heart valves, grafts, catheters, electrocardiogram (ECG), remote cardiac monitoring, and cardiac assist devices. Cardiovascular devices find extensive applications across the healthcare sector as they assist in managing life-threatening conditions effectively, minimizing patient discomfort, and enhancing the quality of life. Nowadays, manufacturers are focusing on developing advanced implantable cardiovascular devices, which is escalating their demand across the globe.
The widespread prevalence of cardiovascular diseases (CVDs) on account of sedentary lifestyles, and unhealthy dietary patterns and habits, such as smoking and alcohol consumption, represents the primary factor driving the market growth. Besides this, the growing geriatric population is another major growth-inducing factor as they are more susceptible to chronic heart ailments. Additionally, there has been a significant increase in the adoption of home healthcare devices. Along with this, the rising need for compact cardiovascular devices that enable patient mobility and simultaneously provide real-time data is augmenting the product demand. Furthermore, the leading players are focusing on research and development (R&D) activities to launch innovative product variants integrated with advanced technologies and features, thereby contributing to the market growth. Moreover, the rising awareness regarding the available cardiovascular devices among the masses and the shifting preferences toward minimally invasive (MI) procedures are accelerating the product adoption rates. Other factors, including the launch of wireless ECG, growing demand for continuous and home-based monitoring, and technological advancements, are also creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type, application and end user.
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Others
Therapeutic and Surgical Devices
Cardiac Rhythm Management (CRM) Devices
Catheter
Stents
Heart Valves
Others
Coronary Artery Disease (CAD)
Cardiac Arrhythmia
Heart Failure
Others
Hospitals
Specialty Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG) and Terumo Cardiovascular Systems Corporation (Terumo Corporation).
Key Questions Answered in This Report
1. What was the size of the global cardiovascular devices market in 2022?
2. What is the expected growth rate of the global cardiovascular devices market during 2023-2028?
3. What has been the impact of COVID-19 on the global cardiovascular devices market?
4. What are the key factors driving the global cardiovascular devices market?
5. What is the breakup of the global cardiovascular devices market based on the device type?
6. What is the breakup of the global cardiovascular devices market based on the application?
7. What is the breakup of the global cardiovascular devices market based on the end user?
8. What are the key regions in the global cardiovascular devices market?
9. Who are the key players/companies in the global cardiovascular devices market?